The current study aimed to examine the capability of using the (R)-[11C]PAQ VEGFR-2-targeting for monitoring anticancer treatment in the MMTV-PyMT/FVB (PyMT) transgenic mouse breast cancer model. This evidence concerns the gene KDR and breast cancer.